Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BRONCHIOLE trial of metoprolol in chronic obstructive pulmonary disease
2017-001507-76Phase 3Active
- Sponsor
- Region Örebro län
- Start
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of metoprolol in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by Region Örebro län. Primary endpoint: Composite of major adverse cardiac and pulmonary events. Started May 2017; status: active.
02
Drugs
metoprolol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2017-001507-76.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-001507-76.